 placebo-control trial continu intraven diltiazem infus heart rate control atrial fibril atrial flutter multicent studi safeti efficaci continu infus intraven diltiazem patient atrial fibril flutter mg mg bolu dose open label intraven diltiazem patient bolu inject double-blind condit continu infus intraven diltiazem mg/h patient placebo patient seventeen patient diltiazem infus none placebo infus therapeut respons patient diltiazem infus respons placebo infus nonrespond double-blind infus addit bolu inject open label intraven diltiazem open label intraven diltiazem infus overal proport patient respons infus intraven diltiazem double-blind open label condit efficaci infus intraven diltiazem similar elderli versu young patient digoxin versu equal kg intraven diltiazem effect atrial fibril atrial flutter signific untoward effect